892 related articles for article (PubMed ID: 15510159)
1. Polyamines and cancer: old molecules, new understanding.
Gerner EW; Meyskens FL
Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
[TBL] [Abstract][Full Text] [Related]
2. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
3. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
4. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
5. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
6. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
7. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
8. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
9. Aspirin and the prevention of colorectal cancer.
Berman KS
N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
[No Abstract] [Full Text] [Related]
10. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
[TBL] [Abstract][Full Text] [Related]
12. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
13. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
Eschwege P
Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg AJ; Zakim D
Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
[TBL] [Abstract][Full Text] [Related]
15. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.
Gerner EW; Meyskens FL; Goldschmid S; Lance P; Pelot D
Amino Acids; 2007 Aug; 33(2):189-95. PubMed ID: 17396214
[TBL] [Abstract][Full Text] [Related]
16. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
17. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
18. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
[TBL] [Abstract][Full Text] [Related]
19. Development of COX inhibitors in cancer prevention and therapy.
Umar A; Viner JL; Anderson WF; Hawk ET
Am J Clin Oncol; 2003 Aug; 26(4):S48-57. PubMed ID: 12902856
[TBL] [Abstract][Full Text] [Related]
20. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
